N J Rupp1, H Moch2. 1. Institut für Pathologie und Molekularpathologie, UniversitätsSpital Zürich, Schmelzbergstr. 12, 8091, Zürich, Schweiz. niels.rupp@usz.ch. 2. Institut für Pathologie und Molekularpathologie, UniversitätsSpital Zürich, Schmelzbergstr. 12, 8091, Zürich, Schweiz.
Abstract
BACKGROUND: In recent years, the characterization of different renal cell carcinoma entities has significantly improved, in particular due to molecular typing. OBJECTIVES: Classical, accepted and emerging renal cell carcinoma entities are described. MATERIALS AND METHODS: A literature search was performed, followed by evaluation and description of the literature focusing on different renal cell carcinoma entities. RESULTS: Classical renal cell carcinoma entities such as clear cell carcinoma, papillary renal cell carcinoma and chromophobe renal cell carcinoma have been expanded in particular by molecular techniques to include, for example, translocation carcinoma or carcinoma with mutations in genes of the mitochondrial energy metabolism. Some rare entities have been accepted by the World Health Organization (WHO) classification, while some are considered as emerging entities. CONCLUSIONS: A range of newly accepted and emerging renal cell carcinoma entities have been introduced in the 2016 WHO classification. A precise and correct diagnosis is of major importance regarding the prognostic assessment, potential new therapeutic strategies and possible hereditary associations.
BACKGROUND: In recent years, the characterization of different renal cell carcinoma entities has significantly improved, in particular due to molecular typing. OBJECTIVES: Classical, accepted and emerging renal cell carcinoma entities are described. MATERIALS AND METHODS: A literature search was performed, followed by evaluation and description of the literature focusing on different renal cell carcinoma entities. RESULTS:Classical renal cell carcinoma entities such as clear cell carcinoma, papillary renal cell carcinoma and chromophobe renal cell carcinoma have been expanded in particular by molecular techniques to include, for example, translocation carcinoma or carcinoma with mutations in genes of the mitochondrial energy metabolism. Some rare entities have been accepted by the World Health Organization (WHO) classification, while some are considered as emerging entities. CONCLUSIONS: A range of newly accepted and emerging renal cell carcinoma entities have been introduced in the 2016 WHO classification. A precise and correct diagnosis is of major importance regarding the prognostic assessment, potential new therapeutic strategies and possible hereditary associations.
Authors: Judy Sarungbam; Rohit Mehra; Scott A Tomlins; Steven C Smith; Gowtham Jayakumaran; Hikmat Al-Ahmadie; Anuradha Gopalan; Sahussapont J Sirintrapun; Samson W Fine; Yanming Zhang; Mahul B Amin; Victor E Reuter; Ying-Bei Chen; Satish K Tickoo Journal: Mod Pathol Date: 2019-01-08 Impact factor: 7.842
Authors: Jorge R Toro; Michael L Nickerson; Ming-Hui Wei; Michelle B Warren; Gladys M Glenn; Maria L Turner; Laveta Stewart; Paul Duray; Ousman Tourre; Nirmala Sharma; Peter Choyke; Pamela Stratton; Maria Merino; McClellan M Walther; W Marston Linehan; Laura S Schmidt; Berton Zbar Journal: Am J Hum Genet Date: 2003-05-22 Impact factor: 11.025
Authors: Sean R Williamson; John N Eble; Mahul B Amin; Nilesh S Gupta; Steven C Smith; Lynette M Sholl; Rodolfo Montironi; Michelle S Hirsch; Jason L Hornick Journal: Mod Pathol Date: 2014-07-18 Impact factor: 7.842
Authors: Pedram Argani; Semra Olgac; Satish K Tickoo; Michael Goldfischer; Holger Moch; David Y Chan; John N Eble; Stephen M Bonsib; Mireya Jimeno; Josep Lloreta; Athanase Billis; Jessica Hicks; Angelo M De Marzo; Victor E Reuter; Marc Ladanyi Journal: Am J Surg Pathol Date: 2007-08 Impact factor: 6.394
Authors: Anthony J Gill; Ondrej Hes; Thomas Papathomas; Monika Šedivcová; Puay Hoon Tan; Abbas Agaimy; Per Arne Andresen; Andrew Kedziora; Adele Clarkson; Christopher W Toon; Loretta Sioson; Nicole Watson; Angela Chou; Julie Paik; Roderick J Clifton-Bligh; Bruce G Robinson; Diana E Benn; Kirsten Hills; Fiona Maclean; Nicolasine D Niemeijer; Ljiljana Vlatkovic; Arndt Hartmann; Eleonora P M Corssmit; Geert J L H van Leenders; Christopher Przybycin; Jesse K McKenney; Cristina Magi-Galluzzi; Asli Yilmaz; Darryl Yu; Katherine D Nicoll; Jim L Yong; Mathilde Sibony; Evgeny Yakirevich; Stewart Fleming; Chung W Chow; Markku Miettinen; Michal Michal; Kiril Trpkov Journal: Am J Surg Pathol Date: 2014-12 Impact factor: 6.394